Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

Amifampridine 4fludarabine phosphate 3gallium 68 PSMA-11 2fludarabine 2carbon-11 acetate 2Whole-Body Irradiation 2Magnetic Resonance Spectroscopy 2Ga(III)-DOTATOC 2Cyclophosphamide 23-Iodobenzylguanidine 2venetoclax 1veliparib 1ulocuplumab 1trametinib 1selinexor 1ponatinib 1pembrolizumab 1pegfilgrastim 1omburtamab I-131 1nirogacestat 1neratinib 1navitoclax 1ganitumab 1gallium Ga 68 dotatate 1fluorodopa F 18 1elotuzumab 1carfilzomib 1asparaginase erwinia chrysanthemi recombinant 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × OTHER × omburtamab I-131 × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡